CORDIS Simple search


Choose your language:
en

Contextual menu:

Path:


Menu
  :: About Projects  


Safety and appropriateness of Growth hormone treatments in Europe

Start date:2009-06-01

End date:2012-11-30

Project Acronym:SAGHE

Project status:Completed

Coordinator

Organization name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Administrative contact Address
Name:Christophe MISSE (Mr) 3 Avenue Victoria

PARIS
FRANCE

Region:ÎLE DE FRANCE Ile de France Paris
Tel:+33-144841770
Fax:+33-144841788
E-mail:Contact
URL:http://www.aphp.fr Organization Type:Education,Other

Description


Objective: Recombinant growth hormone (GH) has been used since 1985. Current indications for GH use in children include GH deficiency and an increasing number of conditions where childhood short stature is not primarily due to deficient GH secretion.

Approximately 40 000 children in the EU are treated with daily injections of GH. The efficacy of GH to increase adult height is undisputed in children with severe GH deficiency but is more limited in other indications where current estimates suggest a gain of about 1 cm of adult height per year of treatment. The clinical significance of height gains has been poorly evaluated. The possibility has been raised that GH use in childhood might increase the risk of cancer later in life. However, little data is available to further explore this concern.

SAGhE is an integrated consortium of paediatric endocrinologist, epidemiologists and biostatisticians that will collect and analyse data to address the questions of appropriateness and safety of childhood GH treatments. The impact on both height and psychosocial components will be evaluated on a large unbiased metacohort of patients followed to adult height. Safety will be evaluated by analysing long term mortality and long term cancer incidence.

The data obtained will then be integrated and disseminated to several levels of users. SAGhE will contribute to the aims of the FP7 Health work programme and to the new Community Action programme of public Health in the field of better use of medicines. It will realize the application of evidence-based medicine in Europe, by the size and design of the study, the independence and scientific quality of data analysis and its translation into evidence-based guidelines. It will be comprehensive at the EU level and will test for national differences. It will address patient safety, one of the key points of the work programme.

SAGhE is unique worldwide in its design, size and potential to answer important questions raised on childhood GH treatments.

Achievements:

General information:

Project Details


Start date:2009-06-01

End date:2012-11-30

Duration:42 months

Project Reference:223497

Project cost:3878026 EURO

Project Funding:2989154 EURO

Programme Acronym: FP7-HEALTH

Programme type:Seventh Framework Programme

Subprogramme Area:Better use of medicines

Contract type:Small or medium-scale focused research project

URL:

Subject index:Medicine, Health

Other Indexes:safety,Growth hormone,short stature,psychosocial impact,cancer risk
 

Other participants

Organization name:THE UNIVERSITY OF MANCHESTER
Administrative contact Address
Name:Liz FAY (Ms.) OXFORD ROAD

MANCHESTER
UNITED KINGDOM

Region:NORTH WEST (UK) GREATER MANCHESTER
Tel:+44-1612757114
Fax:+44-1612752445
E-mail:Contact
URL:http://www.manchester.ac.uk Organization Type:
 
Organization name:KAROLINSKA INSTITUTET
Administrative contact Address
Name:Thomas WALSTAM (Mr) Nobels Vag

STOCKHOLM
SVERIGE

Region:SVERIGE STOCKHOLM
Tel:+46-851773487
Fax:+46-851771774
E-mail:Contact
URL:http://www.ki.se Organization Type:
 
Organization name:UNIVERSITY COLLEGE LONDON
Administrative contact Address
Name:Greta BORG-CARBOTT (Ms.) Gower Street

LONDON
UNITED KINGDOM

Region:SOUTH EAST (UK) GREATER LONDON
Tel:+44-2076796135
Fax:+44-2078132849
E-mail:Contact
URL:http://www.ucl.ac.uk Organization Type:Education,Other
 
Organization name:UNIVERSITAET LEIPZIG
Administrative contact Address
Name:Wieland KIESS (Professor) RITTERSTRASSE

LEIPZIG
DEUTSCHLAND

Region:SACHSEN Leipzig, Kreisfreie Stadt
Tel:+49-3419726330
Fax:+49-3419726349
E-mail:Contact
URL:http://www.uni-leipzig.de Organization Type:
 
Organization name:INSTITUTE OF CANCER RESEARCH - ROYAL CANCER HOSPITAL
Administrative contact Address
Name:Lydia TURNER (Ms.) Old Brompton Road 123

LONDON
UNITED KINGDOM

Region:SOUTH EAST (UK) GREATER LONDON
Tel:+44-2071535219
Fax:+44-2071535534
E-mail:Contact
URL:http://www.icr.ac.uk Organization Type:
 
Organization name:UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Administrative contact Address
Name:Massimo ANDREONI (Professor) VIA ORAZIO RAIMONDO

ROMA
ITALIA

Region:LAZIO Roma
Tel:+39-06-72592226
Fax:+39-06-7236605
E-mail:Contact
URL: Organization Type:
 
Organization name:CLINIQUES UNIVERSITAIRES SAINT-LUC
Administrative contact Address
Name:Michel VAN HASSEL (Mr) AVENUE HIPPOCRATE

BRUXELLES
BELGIQUE-BELGIË

Region:REG.BRUXELLES-CAP./BRUSSELS HFDST. GEW.
Tel:+32-27641510
Fax:+32-27641501
E-mail:Contact
URL:http://www.saintluc.be Organization Type:
 
Organization name:STICHTING KIND EN GROI
Administrative contact Address
Name:Anita HOKKEN-KOELEGA (Professor) WESTZEEDIJK

ROTTERDAM
NEDERLAND

Region:WEST-NEDERLAND ZUID-HOLLAND Groot-Rijnmond
Tel:+31-102251533
Fax:+31-102250133
E-mail:Contact
URL:http://www.groeistichting.nl Organization Type:
 
Organization name:UNIVERSITAET BERN
Administrative contact Address
Name:Primus-eugen, Josef MULLIS (Professor) Hochschulstrasse

BERN
SCHWEIZ/SUISSE/SVIZZERA

Region:ESPACE MITTELLAND Bern
Tel:+41-316329552
Fax:+41-316329550
E-mail:Contact
URL:http://www.unibe.ch Organization Type:
 

Record control number:91240




CORDIS is managed by the Publications Office